Abstract
The aim of this study was to evaluate the profile of BRCA1 mutations among cancer-affected Brazilian women from the Midwest region of Minas Gerais state with clearly defined risk factors for hereditary breast and ovarian cancer (HBOC) syndrome. In this Brazilian region, the first Center for Hereditary Cancer Control began operation in 2011, and 90 % of patients receive assistance from the public health service. Eighteen patients at high risk for HBOC were subjected to molecular analysis. Primers were designed for 22 coding exons of the gene; DNA was extracted; and real-time PCR followed by high-resolution melting reaction was performed. The amplicons were sequenced to confirm the identified profiles. Only exon 11 was directly sequenced due its length. Multiplex ligation-dependent probe amplification (MLPA) was performed for those patients in whom no pathogenic mutations were found. Among the 14 alterations identified in this study, the c.5263_5264insC pathogenic mutation was present in two patients (11.1 %). Four alterations showed no clinical relevance; one exhibited inconclusive clinical relevance according to the examined databases; and eight alterations presented a divergent classification between the databases. No deletions or duplications were found using the MLPA technique. The HRM methodology was highly sensitive in identifying variants in the BRCA1 gene and can dramatically reduce the amount of sequencing required to identify germline mutations in BRCA genes, enabling cheaper tests and increasing their availability to Brazilian women assisted by the public health service.
Similar content being viewed by others
References
Lynch HT, Snyder C, Casey MJ (2013) Hereditary ovarian and breast cancer: what have we learned? Ann Oncol 24(Suppl 8):83–95
Takano E, Mitchell G, Fox SB, Dobrovic A (2008) Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis. BMC Cancer 8:59
De Juan I, Esteban E, Palanca S, Barragán E, Bolufer P (2009) High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations. Breast Cancer Res Treat 115(2):405–414
Druml B, Cichna-Markl M (2014) High resolution melting (HRM) analysis of DNA—its role and potential in food analysis. Food Chem 158:245–254
Hodgson S, Caligo M, Chang-Claude J, Eccles D, Evans G, Moller P et al (2000) A survey of the current clinical facilities for the management of familial cancer in Europe. J Med Genet 37:605–607
Hondow HL, Fox SB, Mitchell G, Scott RJ, Beshay V, Wong SQ et al (2011) A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes. BMC Cancer 11(1):265
De Juan Jiménez I, García Casado Z, Palanca Suela S, Esteban Cardeñosa E, López Guerrero JA, Segura Huerta Á et al (2013) Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence. Fam Cancer 12(4):767–777
Hughes KS. Hughes RiskApps Express Entry. http://66.118.159.147/HRAExpressEntry/(S(k2fucwgitmeepopnkz5ptd50))/Default.aspx. Accessed 10 Jan 2014
National Center for Biotechnology Information—NCBI. http://www.ncbi.nlm.nih.gov/gene/672. Accessed 20 Jan 2014
Primer3. http://frodo.wi.mit.edu/. Accessed 5 Mar 2014
OligoAnalyzer—IDT. http://www.idtdna.com/analyzer/applications/oligoanalyzer. Accessed 5 Mar 2014
Poland Software. http://www.biophys.uni-duesseldorf.de/html/local/POLAND/poland.html. Accessed 12 June 2014
Breast Information Core—BIC. http://research.nhgri.nih.gov/bic. Accessed 27 Mar 2015
Leiden Open Variation Database—LOVD. http://www.lovd.nl/3.0/home. Accessed 27 Mar 2015
Dufloth RM, Carvalho S, Heinrich JK, Shinzato JY, dos Santos CC, Zeferino LC, Schmitt F (2005) Analysis of BRCA 1 and BRCA 2 mutations in Brazilian breast cancer patients with positive family history. Sao Paulo Med J 123(4):192–197
Lourenço JJ, Vargas FR, Bines J, Santos EM, Lasmar CAP, Costa CH et al (2004) BRCA1 mutations in Brazilian patients. Genet Mol Biol 504:500–504
Gomes MCB, Costa MM, Borojevic R, Monteiro ANA, Vieira ER, Koifman S, Koifman RJ, Li S, Royer R, Zhang S, Narod SA (2007) Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil. Breast Cancer Res Treat 103(3):349–353
Carraro DM, Koike Folgueira MAA, Garcia Lisboa BC, Ribeiro Olivieri EH, Vitorino Krepischi AC, de Carvalho AF et al (2013) Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil. PLoS ONE. doi:10.1371/journal.pone.0057581
Esteves VF, Thuler LCS, Amêndola LC, Koifman RJ, Koifman S, Frankel PP et al (2009) Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil. Braz J Med Biol Res 42(5):453–457
Ewald IP, Izetti P, Vargas FR, Moreira MA, Moreira AS, Moreira-Filho CA et al (2011) Prevalence of the BRCA1 founder mutation c.5266dup in Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome. Hered Cancer Clin Pract 9(1):12
Felix GES, Abe-Sandes C, Machado-Lopes TMB, Bomfim TF, Guindalini RSC, Santos VCSAR, Meyer L, Oliveira PC, Neiva JC, Meyer R, Romeo M, Toralles MB, Nascimento I, Abe-Sandes K (2014) Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian population. Hum Genome Var 1:14012. doi:10.1038/hgv.2014.12
Johnson N, Fletcher O, Palles C, Rudd M, Webb E, Sellick G et al (2007) Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. Hum Mol Genet 16(9):1051–1057
Tommasi S, Pilato B, Pinto R, Bruno M, Campana M, Digennaro M et al (2008) Mutation research/fundamental and molecular mechanisms of mutagenesis molecular and in silico analysis of BRCA1 and BRCA2 variants. Mutat Res 644:64–70
Cox DG, Kraft P, Hankinson SE, Hunter DJ (2005) Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer. Breast Cancer Res 7(2):171–175
Greenman J, Mohammed S, Ellis D, Watts S, Scott G, Izatt L et al (1998) Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer. Genes Chromosom Cancer 21:244–249
Bergthorsson JT, Ejlertsen B, Olsen JH, Borg A, Nielsen KV, Barkardottir RB et al (2001) BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. J Med Genet 38(6):361–368
Arnold N, Peper H, Bandick K, Kreikemeier M, Karow D, Teegen B et al (2002) Establishing a control population to screen for the occurrence of nineteen unclassified variants in the BRCA1 gene by denaturing high-performance liquid chromatography. J Chromatogr, B: Anal Technol Biomed Life Sci 782(1–2):99–104
McKean-Cowdin R, Spencer Feigelson H, Xia LY, Pearce CL, Thomas DC, Stram DO et al (2005) BRCA1 variants in a family study of African-American and Latina women. Hum Genet 116(6):497–506
Savas S, Ozcelik H (2005) Phosphorylation states of cell cycle and DNA repair proteins can be altered by the nsSNPs. BMC Cancer 5:107
Tavtigian SV, Deffenbaugh AM, Yin L, Judkins T, Scholl T, Samollow PB et al (2006) Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet 43(4):295–305
Calò V, Bruno L, la Paglia L, Perez M, Margarese N, di Gaudio F et al (2010) The clinical significance of unknown sequence variants in BRCA genes. Cancers (Basel) 2:1644–1660
Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ (2003) High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 49(6):853–860
Krypuy M, Ahmed AA, Etemadmoghadam D, Hyland SJ, DeFazio A, Fox SB et al (2007) High resolution melting for mutation scanning of TP53 exons 5–8. BMC Cancer 7:168
De Leeneer K, Coene I, Poppe B, De Paepe A, Claes K (2009) Genotyping of frequent BRCA1/2 SNPs with unlabeled probes: a supplement to HRMCA mutation scanning, allowing the strong reduction of sequencing burden. J Mol Diagn 11(5):415–419
Chen D, Wang Y-Y, Chuai Z-R, Huang J-F, Wang Y-X, Liu K et al (2014) High-resolution melting analysis for accurate detection of BRAF mutations: a systematic review and meta-analysis. Sci Rep 4:4168
Liu Y, Wu H, Yang X, Xu H, Chen D, Huang Q et al (2014) Diagnostic accuracy of high resolution melting analysis for detection of KRAS mutations: a systematic review and meta-analysis. Sci Rep. doi:10.1038/srep07521
Van Der Stoep N, Van Paridon ÃCDM, Janssens T, Krenkova P, Stambergova A, Macek M et al (2009) Diagnostic guidelines for high-resolution melting curve (HRM) analysis: an interlaboratory validation of BRCA1 mutation scanning using the 96-Well Lightscanner. Hum Mutat 30(6):899–909
Abtahi H, Sadeghi MR, Shabani M, Edalatkhah H, Akhondi MM, Talebi S (2011) Causes of bimodal melting curve: asymmetric guanine-cytosine (GC) distribution causing two peaks in melting curve and affecting their shapes. Afr J Biotechnol 10(50):10196–10203
Erali M, Voelkerding KV, Wittwer CT (2009) High resolution melting applications for clinical laboratory medicine. Exp Mol Pathol 85(1):50–58
Van der Groep P, van der Wall E, van Diest PJ (2011) Pathology of hereditary breast cancer. Cell Oncol (Dordr) 34(2):71–88
Acknowledgments
This study was funded by Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG, APQ-02863-11), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, 401989/2010-0) and Associação de Combate ao Câncer do Centro Oeste de Minas Gerais (ACCCOM).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
de Oliveira, E.S., Soares, B.L., Lemos, S. et al. Screening of the BRCA1 gene in Brazilian patients with breast and/or ovarian cancer via high-resolution melting reaction analysis. Familial Cancer 15, 173–181 (2016). https://doi.org/10.1007/s10689-015-9858-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-015-9858-0